FDA begins push to study psychedelics for mental health disorders
The FDA announced regulatory actions Friday to support development of serotonin-2A agonists and related products, including psychedelic drugs.
Original Source
Read the full article at Upi →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.